Live-Suche
TopFind ruft die neuesten Treffer für deine Suche ab.
Wir haben 5 Live-Ergebnisse für soliris geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die stärksten Themen in dieser Auswahlliste sind Biologics und Rare Disease Treatment.
Quelle: Alexion Pharmaceuticals
Beschreibung
Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system.
Am besten für
Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder und Specialized biologic therapy
Bewertung
Quelle: AstraZeneca Malaysia
Beschreibung
Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases.
Am besten für
Complement inhibition, Rare immune diseases und Infusion therapy
Bewertung
Quelle: AstraZeneca Malaysia
Beschreibung
Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA).
Am besten für
Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions und Local rare disease support
Bewertung
| Vergleichen | Soliris (eculizumab) | Soliris | Soliris 10mg/ml Concentrate for Solution for Infusion |
|---|---|---|---|
| Quelle | Alexion Pharmaceuticals | AstraZeneca Malaysia | AstraZeneca Malaysia |
| Beschreibung | Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system. | Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases. | Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA). |
| Am besten für | Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder und Specialized biologic therapy | Complement inhibition, Rare immune diseases und Infusion therapy | Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions und Local rare disease support |
| Aktion | |||
| Bewertung |
Wenn du mit der ausgewogensten Option starten möchtest, empfehle ich:
"Soliris (eculizumab) von Alexion Pharmaceuticals."
Ich habe dies ausgewählt, weil As the original manufacturer, Alexion provides the most comprehensive safety protocols and patient support through programs like OneSource.